CVS Health®   today announced new steps to further help customers expand adoption of lower-cost biosimilar medications. Effective April 1, 2026, CVS Caremark will begin offering osteoporosis ...

Amgen is running a number of studies of its obesity drug, MariTide.

CVS Caremark will begin offering osteoporosis biosimilars Ospomyv and Stoboclo, as well as generic teriparatide, Bonsity and ...

ANSWER: There is some evidence that calcium supplements do increase the risk of calcium deposition in blood vessels, but the ...

Amgen Inc. ( AMGN) Q4 2025 Earnings Call February 3, 2026 4:30 PM EST My name is Julianne, and I will be your conference facilitator today for the Amgen Q4 2025 Earnings Conference Call. [Operator ...

Alvotech (NASDAQ: ALVO), a global biotechnology company specializing in the development and manufacture of biosimilar ...

When the pancreas stops producing insulin, glucose doesn't enter our cells. Instead, it accumulates in the bloodstream. In ...

Some patients in a clinical trial of one new drug lost so much weight that they became concerned and dropped out.

GLP-1 weight loss drugs have quickly moved from medical journals to household conversations, reshaping how Americans think ...

(Corrects paragraph 5 in February 5 story to say 2025 Prolia sales were $4.4 billion, not $1.05 billion) Feb 5 (Reuters) - ...

Researchers recently tried an experiment: Gather people who had the same kind of lung cancer and put them on the same type of treatments to fire up their immune systems. The only difference was that ...